Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Primary Prevention — Diabetes pathway
Risk category
High
LDL-C target
<1.8 mmol/L
Recommended next step
Escalate to a high-intensity statin
On a statin, but not yet at high intensity, and no intolerance recorded — escalate the dose/potency first.
Current therapy on record
Moderate-intensity statin (Atorvastatin 20 mg) · 22 month(s) on this regimen
Edit
How this was decided
- ✕ LDL-C already at target? 2.4 mmol/L vs. target <1.8 mmol/L.
- ✓ Currently on a statin? Moderate-intensity statin.
- ✕ Statin already at high intensity? Current intensity: moderate.